(WCH) Wacker Chemie - Ratings and Ratios
Silicones, Polymers, Biosolutions, Polysilicon
WCH EPS (Earnings per Share)
WCH Revenue
Description: WCH Wacker Chemie
Wacker Chemie AG is a global chemical company operating through four divisions: Silicones, Polymers, Biosolutions, and Polysilicon, providing a wide range of chemical products. The companys diverse product portfolio is used in various industries, including construction, electronics, pharmaceuticals, and renewable energy.
From a business perspective, Wacker Chemie AG has a significant presence in the specialty chemicals sector, with a market capitalization of approximately €3.63 billion. The companys return on equity (ROE) is around 5.32%, indicating a relatively stable return for shareholders. To further analyze the companys performance, we can look at additional key performance indicators (KPIs) such as revenue growth, EBITDA margin, and debt-to-equity ratio.
Some key KPIs to consider when evaluating Wacker Chemie AG include its revenue growth rate, which has been impacted by the cyclical nature of the chemical industry. The companys EBITDA margin, which is a measure of its profitability, is also an important metric to analyze. Furthermore, the debt-to-equity ratio provides insight into the companys capital structure and financial leverage. As a Trading Analyst, its essential to examine these KPIs to identify trends and potential opportunities.
In terms of valuation, Wacker Chemie AGs price-to-earnings (P/E) ratio is around 14.44, indicating a relatively reasonable valuation compared to its earnings. However, the forward P/E ratio is higher at 21.93, suggesting that the market expects earnings growth in the future. By analyzing these metrics, we can gain a better understanding of the companys financial health and potential for future growth.
WCH Stock Overview
| Market Cap in USD | 4,043m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception |
WCH Stock Ratings
| Growth Rating | -49.7% |
| Fundamental | 29.4% |
| Dividend Rating | 35.0% |
| Return 12m vs S&P 500 | -29.4% |
| Analyst Rating | - |
WCH Dividends
| Dividend Yield 12m | 3.75% |
| Yield on Cost 5y | 3.36% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 80.5% |
| Payout Ratio | 91.9% |
WCH Growth Ratios
| Growth Correlation 3m | -30.3% |
| Growth Correlation 12m | -41.1% |
| Growth Correlation 5y | -53.8% |
| CAGR 5y | -12.70% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.22 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.42 |
| Sharpe Ratio 12m | -1.05 |
| Alpha | -34.10 |
| Beta | 0.946 |
| Volatility | 38.55% |
| Current Volume | 86k |
| Average Volume 20d | 98.6k |
| Stop Loss | 64.2 (-3.6%) |
| Signal | 0.62 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (135.7m TTM) > 0 and > 6% of Revenue (6% = 339.3m TTM) |
| FCFTA -0.07 (>2.0%) and ΔFCFTA -3.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 42.76% (prev 40.31%; Δ 2.46pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 300.8m > Net Income 135.7m (YES >=105%, WARN >=100%) |
| Net Debt (1.21b) to EBITDA (595.3m) ratio: 2.03 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (39.2m) change vs 12m ago -34.69% (target <= -2.0% for YES) |
| Gross Margin 16.07% (prev 14.72%; Δ 1.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 63.48% (prev 64.99%; Δ -1.51pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.79 (EBITDA TTM 595.3m / Interest Expense TTM 23.8m) >= 6 (WARN >= 3) |
Altman Z'' 4.40
| (A) 0.27 = (Total Current Assets 3.70b - Total Current Liabilities 1.28b) / Total Assets 8.80b |
| (B) 0.45 = Retained Earnings (Balance) 3.94b / Total Assets 8.80b |
| (C) 0.02 = EBIT TTM 137.8m / Avg Total Assets 8.91b |
| (D) 0.98 = Book Value of Equity 4.23b / Total Liabilities 4.30b |
| Total Rating: 4.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 29.43
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield -13.94% = -5.0 |
| 3. FCF Margin -11.52% = -4.32 |
| 4. Debt/Equity 0.45 = 2.40 |
| 5. Debt/Ebitda 2.03 = -0.05 |
| 6. ROIC - WACC (= -2.86)% = -3.57 |
| 7. RoE 3.01% = 0.25 |
| 8. Rev. Trend -84.59% = -6.34 |
| 9. EPS Trend -78.63% = -3.93 |
What is the price of WCH shares?
Over the past week, the price has changed by +3.58%, over one month by +5.05%, over three months by -1.11% and over the past year by -18.50%.
Is Wacker Chemie a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WCH is around 58.94 EUR . This means that WCH is currently overvalued and has a potential downside of -11.5%.
Is WCH a buy, sell or hold?
What are the forecasts/targets for the WCH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 68.9 | 3.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 64.4 | -3.3% |
WCH Fundamental Data Overview
Market Cap EUR = 3.47b (3.47b EUR * 1.0 EUR.EUR)
P/E Trailing = 24.5238
P/E Forward = 21.9298
P/S = 0.6128
P/B = 0.7561
P/EG = 2.86
Beta = 0.946
Revenue TTM = 5.66b EUR
EBIT TTM = 137.8m EUR
EBITDA TTM = 595.3m EUR
Long Term Debt = 1.78b EUR (from longTermDebt, last quarter)
Short Term Debt = 153.4m EUR (from shortTermDebt, last quarter)
Debt = 1.94b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.21b EUR (from netDebt column, last quarter)
Enterprise Value = 4.67b EUR (3.47b + Debt 1.94b - CCE 728.5m)
Interest Coverage Ratio = 5.79 (Ebit TTM 137.8m / Interest Expense TTM 23.8m)
FCF Yield = -13.94% (FCF TTM -651.3m / Enterprise Value 4.67b)
FCF Margin = -11.52% (FCF TTM -651.3m / Revenue TTM 5.66b)
Net Margin = 2.40% (Net Income TTM 135.7m / Revenue TTM 5.66b)
Gross Margin = 16.07% ((Revenue TTM 5.66b - Cost of Revenue TTM 4.75b) / Revenue TTM)
Gross Margin QoQ = 11.70% (prev 12.97%)
Tobins Q-Ratio = 0.53 (Enterprise Value 4.67b / Total Assets 8.80b)
Interest Expense / Debt = 0.37% (Interest Expense 7.10m / Debt 1.94b)
Taxrate = -31.18% (negative due to tax credits) (8.70m / -27.9m)
NOPAT = 180.8m (EBIT 137.8m * (1 - -31.18%)) [negative tax rate / tax credits]
Current Ratio = 2.89 (Total Current Assets 3.70b / Total Current Liabilities 1.28b)
Debt / Equity = 0.45 (Debt 1.94b / totalStockholderEquity, last quarter 4.34b)
Debt / EBITDA = 2.03 (Net Debt 1.21b / EBITDA 595.3m)
Debt / FCF = -1.85 (negative FCF - burning cash) (Net Debt 1.21b / FCF TTM -651.3m)
Total Stockholder Equity = 4.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.54% (Net Income 135.7m / Total Assets 8.80b)
RoE = 3.01% (Net Income TTM 135.7m / Total Stockholder Equity 4.51b)
RoCE = 2.19% (EBIT 137.8m / Capital Employed (Equity 4.51b + L.T.Debt 1.78b))
RoIC = 3.41% (NOPAT 180.8m / Invested Capital 5.30b)
WACC = 6.27% (E(3.47b)/V(5.40b) * Re(9.50%) + D(1.94b)/V(5.40b) * Rd(0.37%) * (1-Tc(-0.31)))
Discount Rate = 9.50% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -11.19%
Fair Price DCF = unknown (Cash Flow -651.3m)
EPS Correlation: -78.63 | EPS CAGR: -79.37% | SUE: -0.79 | # QB: 0
Revenue Correlation: -84.59 | Revenue CAGR: -13.90% | SUE: -0.37 | # QB: 0